PandemieGrippaleV1, PascalFrancis, Curation, bibRecord, 001D64

Impact of medical and behavioural factors on influenza-like illness, healthcare-seeking, and antiviral treatment during the 2009 H1N1 pandemic: USA, 2009-2010

Identifieur interne : 001D64 ( PascalFrancis/Curation ); précédent : 001D63; suivant : 001D65

Impact of medical and behavioural factors on influenza-like illness, healthcare-seeking, and antiviral treatment during the 2009 H1N1 pandemic: USA, 2009-2010

Auteurs : M. Biggerstaff [États-Unis] ; M. A. Jhung [États-Unis] ; C. Reed [États-Unis] ; S. Garg [États-Unis] ; L. Balluz [États-Unis] ; A. M. Fry [États-Unis] ; L. Finelli [États-Unis]

Source :

Epidemiology and infection [ 0950-2688 ] ; 2014.

RBID : Pascal:14-0201568

Descripteurs français

Pascal (Inist)
- Antiviral, Traitement, Epidémiologie, Syndrome pseudogrippal, Virus grippal A(H1N1).

English descriptors

KwdEn :
- Antiviral, Epidemiology, Flulike syndrome, Influenzavirus A(H1N1), Treatment.

Abstract

We analysed a cross-sectional telephone survey of U.S. adults to assess the impact of selected characteristics on healthcare-seeking behaviours and treatment practices of people with influenza-like illness (ILI) from September 2009 to March 2010. Of 216431 respondents, 8.1% reported ILI. After adjusting for selected characteristics, respondents aged 18-64 years with the following factors were more likely to report ILI: a diagnosis of asthma [adjusted odds ratio (aOR) 1.88, 95% CI 1.67-2.13] or heart disease (aOR 1.41, 95% CI 1.17-1.70), being disabled (aOR 1.75, 95% CI 1.57-1.96), and reporting financial barriers to healthcare access (aOR 1.63, 95% CI 1.45-1.82). Similar associations were seen in respondents aged ≥ 65 years. Forty percent of respondents with ILI sought healthcare, and 14% who sought healthcare reported receiving influenza antiviral treatment. Treatment was not more frequent in patients with high-risk conditions, except those aged 18-64 years with heart disease (aOR 1.90, 95% CI 1.03-3.51). Of patients at high risk for influenza complications, self-reported ILI was greater but receipt of antiviral treatment was not, despite guidelines recommending their use in this population.

A01	`01`	`1`		`@0 0950-2688`
A02	`01`			`@0 EPINEU`
A03		`1`		`@0 Epidemiol. infect.`
A05				`@2 142`
A06				`@2 1`
A08	`01`	`1`	`ENG`	`@1 Impact of medical and behavioural factors on influenza-like illness, healthcare-seeking, and antiviral treatment during the 2009 H1N1 pandemic: USA, 2009-2010`
A11	`01`	`1`		`@1 BIGGERSTAFF (M.)`
A11	`02`	`1`		`@1 JHUNG (M. A.)`
A11	`03`	`1`		`@1 REED (C.)`
A11	`04`	`1`		`@1 GARG (S.)`
A11	`05`	`1`		`@1 BALLUZ (L.)`
A11	`06`	`1`		`@1 FRY (A. M.)`
A11	`07`	`1`		`@1 FINELLI (L.)`
A14	`01`			`@1 Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention @2 Atlanta, GA @3 USA @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 4 aut. @Z 6 aut. @Z 7 aut.`
A14	`02`			`@1 Epidemic Intelligence Service, Centers for Disease Control and Prevention @2 Atlanta, GA @3 USA @Z 4 aut.`
A14	`03`			`@1 Division of Behavioral Surveillance, Office of Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention @2 Atlanta, GA @3 USA @Z 5 aut.`
A20				`@1 114-125`
A21				`@1 2014`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 6056 @5 354000501655550140`
A44				`@0 0000 @1 © 2014 INIST-CNRS. All rights reserved.`
A45				`@0 40 ref.`
A47	`01`	`1`		`@0 14-0201568`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Epidemiology and infection`
A66	`01`			`@0 GBR`
C01	`01`		`ENG`	@0 We analysed a cross-sectional telephone survey of U.S. adults to assess the impact of selected characteristics on healthcare-seeking behaviours and treatment practices of people with influenza-like illness (ILI) from September 2009 to March 2010. Of 216431 respondents, 8.1% reported ILI. After adjusting for selected characteristics, respondents aged 18-64 years with the following factors were more likely to report ILI: a diagnosis of asthma [adjusted odds ratio (aOR) 1.88, 95% CI 1.67-2.13] or heart disease (aOR 1.41, 95% CI 1.17-1.70), being disabled (aOR 1.75, 95% CI 1.57-1.96), and reporting financial barriers to healthcare access (aOR 1.63, 95% CI 1.45-1.82). Similar associations were seen in respondents aged ≥ 65 years. Forty percent of respondents with ILI sought healthcare, and 14% who sought healthcare reported receiving influenza antiviral treatment. Treatment was not more frequent in patients with high-risk conditions, except those aged 18-64 years with heart disease (aOR 1.90, 95% CI 1.03-3.51). Of patients at high risk for influenza complications, self-reported ILI was greater but receipt of antiviral treatment was not, despite guidelines recommending their use in this population.
C02	`01`	`X`		`@0 002A05`
C03	`01`	`X`	`FRE`	`@0 Antiviral @5 05`
C03	`01`	`X`	`ENG`	`@0 Antiviral @5 05`
C03	`01`	`X`	`SPA`	`@0 Antiviral @5 05`
C03	`02`	`X`	`FRE`	`@0 Traitement @5 06`
C03	`02`	`X`	`ENG`	`@0 Treatment @5 06`
C03	`02`	`X`	`SPA`	`@0 Tratamiento @5 06`
C03	`03`	`X`	`FRE`	`@0 Epidémiologie @5 07`
C03	`03`	`X`	`ENG`	`@0 Epidemiology @5 07`
C03	`03`	`X`	`SPA`	`@0 Epidemiología @5 07`
C03	`04`	`X`	`FRE`	`@0 Syndrome pseudogrippal @4 CD @5 96`
C03	`04`	`X`	`ENG`	`@0 Flulike syndrome @4 CD @5 96`
C03	`05`	`X`	`FRE`	`@0 Virus grippal A(H1N1) @4 CD @5 97`
C03	`05`	`X`	`ENG`	`@0 Influenzavirus A(H1N1) @4 CD @5 97`
N21				`@1 251`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000055

Links to Exploration step

Pascal:14-0201568

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Impact of medical and behavioural factors on influenza-like illness, healthcare-seeking, and antiviral treatment during the 2009 H1N1 pandemic: USA, 2009-2010</title>
<author><name sortKey="Biggerstaff, M" sort="Biggerstaff, M" uniqKey="Biggerstaff M" first="M." last="Biggerstaff">M. Biggerstaff</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Jhung, M A" sort="Jhung, M A" uniqKey="Jhung M" first="M. A." last="Jhung">M. A. Jhung</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Reed, C" sort="Reed, C" uniqKey="Reed C" first="C." last="Reed">C. Reed</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Garg, S" sort="Garg, S" uniqKey="Garg S" first="S." last="Garg">S. Garg</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Epidemic Intelligence Service, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Balluz, L" sort="Balluz, L" uniqKey="Balluz L" first="L." last="Balluz">L. Balluz</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Division of Behavioral Surveillance, Office of Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Fry, A M" sort="Fry, A M" uniqKey="Fry A" first="A. M." last="Fry">A. M. Fry</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Finelli, L" sort="Finelli, L" uniqKey="Finelli L" first="L." last="Finelli">L. Finelli</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">14-0201568</idno>
<date when="2014">2014</date>
<idno type="stanalyst">PASCAL 14-0201568 INIST</idno>
<idno type="RBID">Pascal:14-0201568</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000055</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001D64</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Impact of medical and behavioural factors on influenza-like illness, healthcare-seeking, and antiviral treatment during the 2009 H1N1 pandemic: USA, 2009-2010</title>
<author><name sortKey="Biggerstaff, M" sort="Biggerstaff, M" uniqKey="Biggerstaff M" first="M." last="Biggerstaff">M. Biggerstaff</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Jhung, M A" sort="Jhung, M A" uniqKey="Jhung M" first="M. A." last="Jhung">M. A. Jhung</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Reed, C" sort="Reed, C" uniqKey="Reed C" first="C." last="Reed">C. Reed</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Garg, S" sort="Garg, S" uniqKey="Garg S" first="S." last="Garg">S. Garg</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Epidemic Intelligence Service, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Balluz, L" sort="Balluz, L" uniqKey="Balluz L" first="L." last="Balluz">L. Balluz</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Division of Behavioral Surveillance, Office of Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Fry, A M" sort="Fry, A M" uniqKey="Fry A" first="A. M." last="Fry">A. M. Fry</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Finelli, L" sort="Finelli, L" uniqKey="Finelli L" first="L." last="Finelli">L. Finelli</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Epidemiology and infection</title>
<title level="j" type="abbreviated">Epidemiol. infect.</title>
<idno type="ISSN">0950-2688</idno>
<imprint><date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Epidemiology and infection</title>
<title level="j" type="abbreviated">Epidemiol. infect.</title>
<idno type="ISSN">0950-2688</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral</term>
<term>Epidemiology</term>
<term>Flulike syndrome</term>
<term>Influenzavirus A(H1N1)</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Antiviral</term>
<term>Traitement</term>
<term>Epidémiologie</term>
<term>Syndrome pseudogrippal</term>
<term>Virus grippal A(H1N1)</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We analysed a cross-sectional telephone survey of U.S. adults to assess the impact of selected characteristics on healthcare-seeking behaviours and treatment practices of people with influenza-like illness (ILI) from September 2009 to March 2010. Of 216431 respondents, 8.1% reported ILI. After adjusting for selected characteristics, respondents aged 18-64 years with the following factors were more likely to report ILI: a diagnosis of asthma [adjusted odds ratio (aOR) 1.88, 95% CI 1.67-2.13] or heart disease (aOR 1.41, 95% CI 1.17-1.70), being disabled (aOR 1.75, 95% CI 1.57-1.96), and reporting financial barriers to healthcare access (aOR 1.63, 95% CI 1.45-1.82). Similar associations were seen in respondents aged ≥ 65 years. Forty percent of respondents with ILI sought healthcare, and 14% who sought healthcare reported receiving influenza antiviral treatment. Treatment was not more frequent in patients with high-risk conditions, except those aged 18-64 years with heart disease (aOR 1.90, 95% CI 1.03-3.51). Of patients at high risk for influenza complications, self-reported ILI was greater but receipt of antiviral treatment was not, despite guidelines recommending their use in this population.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0950-2688</s0>
</fA01>
<fA02 i1="01"><s0>EPINEU</s0>
</fA02>
<fA03 i2="1"><s0>Epidemiol. infect.</s0>
</fA03>
<fA05><s2>142</s2>
</fA05>
<fA06><s2>1</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Impact of medical and behavioural factors on influenza-like illness, healthcare-seeking, and antiviral treatment during the 2009 H1N1 pandemic: USA, 2009-2010</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>BIGGERSTAFF (M.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>JHUNG (M. A.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>REED (C.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>GARG (S.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>BALLUZ (L.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>FRY (A. M.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>FINELLI (L.)</s1>
</fA11>
<fA14 i1="01"><s1>Epidemiology and Prevention Branch, Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Epidemic Intelligence Service, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Division of Behavioral Surveillance, Office of Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA20><s1>114-125</s1>
</fA20>
<fA21><s1>2014</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>6056</s2>
<s5>354000501655550140</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2014 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>40 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>14-0201568</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Epidemiology and infection</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>We analysed a cross-sectional telephone survey of U.S. adults to assess the impact of selected characteristics on healthcare-seeking behaviours and treatment practices of people with influenza-like illness (ILI) from September 2009 to March 2010. Of 216431 respondents, 8.1% reported ILI. After adjusting for selected characteristics, respondents aged 18-64 years with the following factors were more likely to report ILI: a diagnosis of asthma [adjusted odds ratio (aOR) 1.88, 95% CI 1.67-2.13] or heart disease (aOR 1.41, 95% CI 1.17-1.70), being disabled (aOR 1.75, 95% CI 1.57-1.96), and reporting financial barriers to healthcare access (aOR 1.63, 95% CI 1.45-1.82). Similar associations were seen in respondents aged ≥ 65 years. Forty percent of respondents with ILI sought healthcare, and 14% who sought healthcare reported receiving influenza antiviral treatment. Treatment was not more frequent in patients with high-risk conditions, except those aged 18-64 years with heart disease (aOR 1.90, 95% CI 1.03-3.51). Of patients at high risk for influenza complications, self-reported ILI was greater but receipt of antiviral treatment was not, despite guidelines recommending their use in this population.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002A05</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Antiviral</s0>
<s5>05</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Antiviral</s0>
<s5>05</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Antiviral</s0>
<s5>05</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Traitement</s0>
<s5>06</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Treatment</s0>
<s5>06</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>06</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Epidémiologie</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Epidemiology</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Epidemiología</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Syndrome pseudogrippal</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Flulike syndrome</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Virus grippal A(H1N1)</s0>
<s4>CD</s4>
<s5>97</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Influenzavirus A(H1N1)</s0>
<s4>CD</s4>
<s5>97</s5>
</fC03>
<fN21><s1>251</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D64 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 001D64 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:14-0201568
   |texte=   Impact of medical and behavioural factors on influenza-like illness, healthcare-seeking, and antiviral treatment during the 2009 H1N1 pandemic: USA, 2009-2010
}}

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021

	Serveur d'exploration sur les pandémies grippales
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les pandémies grippales

Impact of medical and behavioural factors on influenza-like illness, healthcare-seeking, and antiviral treatment during the 2009 H1N1 pandemic: USA, 2009-2010

Impact of medical and behavioural factors on influenza-like illness, healthcare-seeking, and antiviral treatment during the 2009 H1N1 pandemic: USA, 2009-2010

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri